On September 9, 2020 Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported that Dr. Helen Torley, president and chief executive officer, will be participating in the following investor conferences (Press release, Halozyme, SEP 9, 2020, View Source [SID1234564805]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Virtual Global Healthcare Conference at 10:40 a.m. ET / 7:40 a.m. PT on Tuesday, September 15, 2020
Morgan Stanley Virtual Global Healthcare Conference at 2:00 p.m. ET / 11:00 a.m. PT on Thursday, September 17, 2020
A live webcast of each event can be accessed through the "Investors" section of Halozyme’s website (www.halozyme.com), and an archive will be made available for 90 days following each event. To access a live webcast, please visit Halozyme’s website (www.halozyme.com) approximately 15 minutes prior to the presentation to register and download any necessary audio software.